The global atherectomy devices market was valued at $ 787.12 million in 2021 and is projected to reach $2.11 Billion by 2031, registering a CAGR of 10.5% from 2022 to 2031.
Atherectomy devices are medical devices used to remove plaque buildup in arteries, particularly in cases of atherosclerosis. Atherosclerosis is a disease of the arteries in which fatty deposits, known as plaques, build up on the inner walls of the arteries, leading to their narrowing and hardening.
Atherectomy devices are medical devices used to remove atherosclerotic plaque from the walls of arteries. Atherectomy devices are often used in conjunction with other treatments for peripheral artery disease (PAD), such as balloon angioplasty or stenting, to improve blood flow, and alleviate symptoms. They are typically performed in a hospital or outpatient setting and are usually done under local anesthesia. Like all medical procedures, atherectomy carries some risks, including bleeding, infection, and damage to the artery. However, with proper patient selection and technique, atherectomy can be a safe and effective treatment option for peripheral artery disease (PAD).
The surge in demand for atherectomy devices is due to rise in incidence of cardiovascular diseases, such as atherosclerosis, Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Atherosclerosis, which is a condition characterized by the buildup of plaque inside the arteries, leading to the narrowing and hardening of the arteries. This can result in reduced blood flow to vital organs such as the heart and brain, which can lead to serious health problems such as heart attacks and strokes. Furthermore, the prevalence of atherosclerosis has increased in recent years due to various factors, including changes in lifestyle and an aging population. In 2021, according to a report by American Heart Association, atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide.
Furthermore, the elderly population is at a higher risk of developing cardiovascular diseases and other related conditions, such as diabetes and hypertension due to the fact that blood vessels lose elasticity with age, becoming stiffer and less able to expand and contract as needed to regulate blood pressure. In addition, some elderly individuals may have a genetic predisposition to cardiovascular disease (CVDs), such as a family history of heart disease or stroke. Moreover, increase in demand for minimally invasive procedures due to reduced pain, shorter hospital stays, and faster recovery times is expected to drive the market growth during the forecast period.
In addition, the rise in healthcare expenditure in both developed and developing countries drives demand for atherectomy devices, as healthcare providers seek to offer the latest and most effective treatments to their patients. Thus, these were the major factors that contribute to the growth of the atherectomy devices market. However, factors such as high cost of atherectomy treatment, limited availability of skilled healthcare professionals, and risk of complications might restrain the growth of the atherectomy devices market.
The atherectomy devices market is segmented into type, end user, and region. By type, the market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc.
Atherectomy devices are medical devices used to remove plaque buildup in arteries, particularly in cases of atherosclerosis. Atherosclerosis is a disease of the arteries in which fatty deposits, known as plaques, build up on the inner walls of the arteries, leading to their narrowing and hardening.
Atherectomy devices are medical devices used to remove atherosclerotic plaque from the walls of arteries. Atherectomy devices are often used in conjunction with other treatments for peripheral artery disease (PAD), such as balloon angioplasty or stenting, to improve blood flow, and alleviate symptoms. They are typically performed in a hospital or outpatient setting and are usually done under local anesthesia. Like all medical procedures, atherectomy carries some risks, including bleeding, infection, and damage to the artery. However, with proper patient selection and technique, atherectomy can be a safe and effective treatment option for peripheral artery disease (PAD).
The surge in demand for atherectomy devices is due to rise in incidence of cardiovascular diseases, such as atherosclerosis, Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Atherosclerosis, which is a condition characterized by the buildup of plaque inside the arteries, leading to the narrowing and hardening of the arteries. This can result in reduced blood flow to vital organs such as the heart and brain, which can lead to serious health problems such as heart attacks and strokes. Furthermore, the prevalence of atherosclerosis has increased in recent years due to various factors, including changes in lifestyle and an aging population. In 2021, according to a report by American Heart Association, atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide.
Furthermore, the elderly population is at a higher risk of developing cardiovascular diseases and other related conditions, such as diabetes and hypertension due to the fact that blood vessels lose elasticity with age, becoming stiffer and less able to expand and contract as needed to regulate blood pressure. In addition, some elderly individuals may have a genetic predisposition to cardiovascular disease (CVDs), such as a family history of heart disease or stroke. Moreover, increase in demand for minimally invasive procedures due to reduced pain, shorter hospital stays, and faster recovery times is expected to drive the market growth during the forecast period.
In addition, the rise in healthcare expenditure in both developed and developing countries drives demand for atherectomy devices, as healthcare providers seek to offer the latest and most effective treatments to their patients. Thus, these were the major factors that contribute to the growth of the atherectomy devices market. However, factors such as high cost of atherectomy treatment, limited availability of skilled healthcare professionals, and risk of complications might restrain the growth of the atherectomy devices market.
The atherectomy devices market is segmented into type, end user, and region. By type, the market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the atherectomy devices market analysis from 2021 to 2031 to identify the prevailing atherectomy devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the atherectomy devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global atherectomy devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Rotational Atherectomy Devices
- Orbital Atherectomy Devices
- Others
- Directional Atherectomy Devices
By End User
- Hospitals
- Ambulatory surgery centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Medtronic plc
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Becton, Dickinson and Company
- AngioDynamics Inc.
- Rex medical
- Nipro Corporation
- Invamed medical
- Avinger Inc.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ATHERECTOMY DEVICES MARKET, BY PRODUCT
CHAPTER 5: ATHERECTOMY DEVICES MARKET, BY END USER
CHAPTER 6: ATHERECTOMY DEVICES MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Medtronic plc
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Becton, Dickinson and Company
- AngioDynamics Inc.
- Rex medical
- Nipro Corporation
- Invamed medical
- Avinger Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
